share_log

Canaccord Genuity Maintains Buy on Inari Medical, Maintains $75 Price Target

Benzinga ·  Apr 12 12:00

Canaccord Genuity analyst William Plovanic maintains Inari Medical (NASDAQ:NARI) with a Buy and maintains $75 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment